Clinicopathological Significance of Taz and VGLL1 Expression in Early Stage Ovarian Cancer. A study by Spanish Group for Ovarian Cancer Research (GEICO).

被引:0
|
作者
Antonio Lopez-Guerrero, Jose
Gutierrez Pecharroman, Ana
Palacios, Jose
Cristobal Lana, Eva Maria
Romero, Ignacio
Hardisson, David
Vera-Sempere, Francisco
Illueca, Carmen
Vieites, Begoaa
Garcia, Angel
Ibarra de la Rosa, Javier
Alonso, Sofia Hakin
Guarch Troyas, Rosa
Andrada, Encarna
Montes, Santiago
Pastor, Francisco
Carmen Gomez, Maria
Amparo Torroba, Maria
D'Angelo, Emanuela
Poveda, Andres
机构
[1] Inst Valenciano Oncol, Mol Biol Lab, Valencia, Spain
[2] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[3] Hosp Univ Ramon y Cajal, Dept Pathol, Madrid, Spain
[4] Inst Valenciano Oncol, Valencia, Spain
[5] IdiPAZ, Hosp Univ La Paz, Dept Pathol, Madrid, Spain
[6] Hosp Univ La Fe, Valencia, Spain
[7] Inst Valenciano Oncol, Area Clin Oncol Ginecol, Valencia, Spain
[8] Hosp Virgen del Rocio, Seville, Spain
[9] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain
[10] Hosp Son Llatzer, Palma De Mallorca, Spain
[11] Hosp Miguel Servet, Zaragoza, Spain
[12] Hosp Navarra, Pamplona, Spain
[13] Hosp Gen Elche, Elche, Spain
[14] Hosp Marques de Valdecillas, Santander, Spain
[15] Univ Hosp Reina Sofia, Murcia, Spain
[16] Hosp Badalona Germans Trias & Pujol, Dept Pathol, Barcelona, Spain
[17] Hosp Virgen Arrixaca, Murcia, Spain
[18] Hosp Santa Creu & Sant Pau, Barcelona, Spain
关键词
D O I
10.1200/jco.2015.33.15_suppl.e16583
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16583
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Expression of Cyclooxygenase-1 in Epithelial Ovarian Cancer: A Clinicopathological Study
    Khunnarong, Jakkapan
    Tangjitgamol, Siriwan
    Manusirivithaya, Sumonmal
    Suekwattana, Pacheun
    Leelahakorn, Surawute
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2008, 9 (04) : 757 - 762
  • [22] VGLL1 stabilization of cytoplasmic TAZ promotes EGFR expression and maintains tumor initiating cells in breast cancer independent of TEAD
    Parimita, Shubhashree
    Das, Amitava
    Samanta, Sanjoy
    CELLULAR SIGNALLING, 2024, 118
  • [23] A multicenter clinical registry with associated biological samples of gynecological cancer patients: Pilot study of the Spanish Ovarian Cancer Research Group (GEICO 81-T)
    Lopez Guerrero, J. A.
    Mendiola, M.
    Perez-Fidalgo, J. A.
    Romero, I.
    Gomez Raposo, C.
    Herrero, A.
    Alarcon, J. D.
    Esteban Esteban, C.
    Marquina Ospina, G.
    Rubio, M. J.
    Sanchez, L.
    Guerra, E. M.
    Gonzalez Martin, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S635 - S636
  • [24] Prolonged infusion of gemcitabine in patients with platinum resistant or refractory recurrent ovarian carcinoma:: A phase II study Of GEICO (Spanish Group for investigation on ovarian cancer).
    Ojeda, B
    Gonzaléz-Martín, A
    Mellado, B
    Bover, I
    Fabregat, X
    Rubio, MJ
    Alonso, L
    Lianes, P
    Churruca, C
    Poveda, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 479S - 479S
  • [25] Clinicopathological significance of steroidogenic factor-1 expression in ovarian cancer versus ovarian sex cord stromal tumor
    Hu, Zhuo-ying
    Tang, Liang-dan
    Zhang, Hong-yu
    Niu, Jing-ya
    Lou, Meng
    TUMOR BIOLOGY, 2015, 36 (03) : 1429 - 1435
  • [26] EXPRESSION OF DNA REPAIR GENES AS BIOMARKERS OF OUTCOME IN EPITHELIAL OVARIAN CANCER: A GEICO STUDY
    Poveda, A. M.
    Casado, A.
    Cervantes, A.
    Taron, M.
    Romero, I.
    Bover, I.
    Martin, A. Gonzalez
    Oaknin, A.
    Ojeda, B.
    Lopez-Guerrero, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 307 - 307
  • [27] Phase II trial of temozolomide as first-line treatment for patients with advanced gynecological sarcoma: A Spanish Group for Research on Sarcomas (GEIS) and Spanish Ovarian Cancer Research Group (GEICO) study.
    Del Muro, X. Garcia
    Poveda, A.
    Buesa, J. M.
    Trufero, J. Martinez
    De Sande, L. M.
    Calvo, E.
    Escudero, P.
    Pousa, A. Lopez
    Fabregat, X.
    Casado, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 537S - 537S
  • [28] Adequacy of surgical staging to predict survival in early stage ovarian cancer.
    Occhiogrosso, Rachel Hope
    Steinhoff, Margaret
    Raker, Christina
    Has, Phinnara
    DiSilvestro, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Outcome research: Ambulatory intraperitoneal chemotherapy in stage IIIC ovarian cancer.
    Garcia Gerardi, Carlos
    Vidaurreta, Javier
    Gil Deza, Ernesto
    Kohen, Nelson
    Levit, Claudio
    Morgenfeld, Eduardo L.
    Alessandria, Sebastian
    Rivarola, Edgardo G. J.
    Gercovich, Felipe G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Inter-laboratory evaluation of somatic BRCA mutations in clinical practice: a ring trial of the Spanish Group of Research in Ovarian Cancer (GEICO)
    Garcia-Casado, Z.
    Vivancos, A.
    Alkorta-Aranburu, G.
    Palacios, J.
    Mendiola, M.
    Antunez, J. R.
    Moreno-Bueno, G.
    Fabra, T. Imizcoz
    Caniego-Casas, T.
    Abdulaker, I.
    Diez, E.
    Lopez-Guerrero, J. A.
    Romero, I.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S135 - S135